Preliminary scientific tests point out conolidine may inhibit specific ion channels, cutting down neuronal excitability and limiting suffering signals. This mechanism is especially pertinent in neuropathic agony, the place abnormal signaling results in persistent discomfort. On top of that, conolidine appears to affect G protein-coupled receptor (G